Clinical Trials Browser

Phase 1/2 × NIH × Infliximab × Clear all

NCT00325078 2015-12-29

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

Phase 1/2 Terminated

40 enrolled 11 charts

Crohn Disease, Granulomatous Disease, Chronic, Inflammatory Bowel Diseases